Skip to main content
Fig. 5 | BMC Infectious Diseases

Fig. 5

From: Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003–2012

Fig. 5

HPV seroprevalence and vaccination status for women ages 14–59. Seroprevalence is given a) by age and b) by race. The two bars in each group represent 2007–08 and 2009–10 respectively. The shaded portion of the bar gives the fraction of those who are seropositive and also reported being vaccinated. Women who reported receiving at least one dose are considered vaccinated

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us